Literature DB >> 24029863

European Society of Hypertension position paper on ambulatory blood pressure monitoring.

Eoin O'Brien1, Gianfranco Parati, George Stergiou, Roland Asmar, Laurie Beilin, Grzegorz Bilo, Denis Clement, Alejandro de la Sierra, Peter de Leeuw, Eamon Dolan, Robert Fagard, John Graves, Geoffrey A Head, Yutaka Imai, Kazuomi Kario, Empar Lurbe, Jean-Michel Mallion, Giuseppe Mancia, Thomas Mengden, Martin Myers, Gbenga Ogedegbe, Takayoshi Ohkubo, Stefano Omboni, Paolo Palatini, Josep Redon, Luis M Ruilope, Andrew Shennan, Jan A Staessen, Gert vanMontfrans, Paolo Verdecchia, Bernard Waeber, Jiguang Wang, Alberto Zanchetti, Yuqing Zhang.   

Abstract

Ambulatory blood pressure monitoring (ABPM) is being used increasingly in both clinical practice and hypertension research. Although there are many guidelines that emphasize the indications for ABPM, there is no comprehensive guideline dealing with all aspects of the technique. It was agreed at a consensus meeting on ABPM in Milan in 2011 that the 34 attendees should prepare a comprehensive position paper on the scientific evidence for ABPM.This position paper considers the historical background, the advantages and limitations of ABPM, the threshold levels for practice, and the cost-effectiveness of the technique. It examines the need for selecting an appropriate device, the accuracy of devices, the additional information and indices that ABPM devices may provide, and the software requirements.At a practical level, the paper details the requirements for using ABPM in clinical practice, editing considerations, the number of measurements required, and the circumstances, such as obesity and arrhythmias, when particular care needs to be taken when using ABPM.The clinical indications for ABPM, among which white-coat phenomena, masked hypertension, and nocturnal hypertension appear to be prominent, are outlined in detail along with special considerations that apply in certain clinical circumstances, such as childhood, the elderly and pregnancy, and in cardiovascular illness, examples being stroke and chronic renal disease, and the place of home measurement of blood pressure in relation to ABPM is appraised.The role of ABPM in research circumstances, such as pharmacological trials and in the prediction of outcome in epidemiological studies is examined and finally the implementation of ABPM in practice is considered in relation to the issue of reimbursement in different countries, the provision of the technique by primary care practices, hospital clinics and pharmacies, and the growing role of registries of ABPM in many countries.

Entities:  

Mesh:

Year:  2013        PMID: 24029863     DOI: 10.1097/HJH.0b013e328363e964

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  406 in total

1.  Effects of nondipping pattern on systemic inflammation in obstructive sleep apnea.

Authors:  Sevinc Sarinc Ulasli; Muzaffer Sarıaydın; Ersin Gunay; Bilal Halici; Sefa Celik; Tulay Koyuncu; Sena Ulu; Mehmet Unlu
Journal:  Sleep Breath       Date:  2015-02-28       Impact factor: 2.816

2.  Ambulatory Blood Pressure Variability Increases Over a 10-Year Follow-Up in Community-Dwelling Older People.

Authors:  Claire McDonald; Mark S Pearce; Joanna Wincenciak; Simon R J Kerr; Julia L Newton
Journal:  Am J Hypertens       Date:  2015-08-26       Impact factor: 2.689

3.  Three-year change in endothelin-1 and markers of vascular remodelling in a bi-ethnic South African cohort: the SABPA study.

Authors:  C S du Plooy; C M C Mels; H W Huisman; R Kruger
Journal:  J Hum Hypertens       Date:  2017-07-20       Impact factor: 3.012

4.  Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients.

Authors:  Francesca Mallamaci; Giovanni Tripepi; Graziella D'Arrigo; Silvio Borrelli; Carlo Garofalo; Giovanna Stanzione; Michele Provenzano; Luca De Nicola; Giuseppe Conte; Roberto Minutolo; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-02       Impact factor: 8.237

Review 5.  The complexity of masked hypertension: diagnostic and management challenges.

Authors:  Stanley S Franklin; Nathan D Wong
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

6.  Night-time systolic blood pressure and subclinical cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study.

Authors:  Koki Nakanishi; Zhezhen Jin; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Joseph E Schwartz; Tetz C Lee; Aylin Tugcu; Mitsuhiro Yoshita; Charles DeCarli; Clinton B Wright; Ralph L Sacco; Marco R Di Tullio
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-07-01       Impact factor: 6.875

7.  The use of ambulatory blood pressure monitoring among Medicare beneficiaries in 2007-2010.

Authors:  Daichi Shimbo; Shia T Kent; Keith M Diaz; Lei Huang; Anthony J Viera; Meredith Kilgore; Suzanne Oparil; Paul Muntner
Journal:  J Am Soc Hypertens       Date:  2014-09-18

8.  Prevalence, Determinants, and Clinical Significance of Masked Hypertension in a Population-Based Sample of African Americans: The Jackson Heart Study.

Authors:  Keith M Diaz; Praveen Veerabhadrappa; Michael D Brown; Matthew C Whited; Patricia M Dubbert; DeMarc A Hickson
Journal:  Am J Hypertens       Date:  2014-12-12       Impact factor: 2.689

9.  Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries.

Authors:  Shia T Kent; Daichi Shimbo; Lei Huang; Keith M Diaz; Anthony J Viera; Meredith Kilgore; Suzanne Oparil; Paul Muntner
Journal:  J Am Soc Hypertens       Date:  2014-10-02

Review 10.  Drug treatment of hypertension in pregnancy.

Authors:  Catherine M Brown; Vesna D Garovic
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.